Boston Scientific has recently reported the results of the Optical Coherence Tomography Drug Eluting ... of this stent platform in larger groups of patients. Elixir Medical (CA, USA) reported ...
Abbott (NYSE:ABT) today announced data demonstrating the long-term effectiveness of its Esprit BTK drug-eluting stent.
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
You’ll usually need to continue dual antiplatelet drug therapy for a year after a drug-eluting ... emergency medical attention any time you develop potential side effects of stent thrombosis ...
Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced late-breaking data demonstrating significant b ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Results from the large-scale randomized ECLIPSE trial found that a lesion preparation strategy of routine orbital atherectomy had similar outcomes compared with conventional balloon angioplasty prior ...
Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...
Non-drug eluting devices, such as bare-metal stents, catheters, and implantable medical devices, are widely used in procedures where drug elution is not necessary, or where a more mechanical or ...
For percutaneous coronary intervention (PCI) on de novo lesions, the DynamX bioadaptor not only matched drug-eluting stents ...
As per GlobalData’s report, India’s coronary drug eluting stent market accounts for around ... potential to enhance its role in the global medical device industry”, Chauhan added.
Abbott has unveiled positive long-term data for its Esprit below-the-knee (BTK) stent in treating the most severe form of peripheral artery disease (PAD). The data, which was presented as a ...